ten23 health provides formulation, analytical, and process development services for the pharmaceutical and biotech industries, focusing on the sterile manufacturing of injectable treatments. The company addresses the need for differentiated, stable, and safe drug products by combining scientific expertise with sustainable practices in drug development and manufacturing.
Funding
$94.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Pharmaceutical and biotech companies face challenges in developing differentiated, stable, and safe injectable treatments, requiring specialized expertise in formulation, analytical testing, and sterile manufacturing. Meeting stringent regulatory requirements while ensuring sustainable practices adds further complexity to the drug development and manufacturing process.
Solution
ten23 health is a contract development and manufacturing organization (CDMO) that provides comprehensive services for the pharmaceutical and biotech industries, focusing on sterile injectable treatments. The company supports clients in pharmaceutical product development, drug product manufacturing, and analytical testing and quality control. ten23 health combines scientific expertise with industry and regulatory knowledge to develop differentiated and stable drug products while adhering to sustainable practices.
Target Audience
ten23 health primarily serves pharmaceutical companies and biotech startups seeking expertise in the development, manufacturing, and testing of sterile injectable medicines.
Features
- Pharmaceutical product development services, including development strategy, formulation design, molecule selection and characterization, and drug/device integration
- Drug product manufacturing, including manufacturing process transfer, characterization and validation, clinical fill & finish, and commercial supplies
- Analytical development and testing services for release and stability testing of sterile drug products according to cGMP standards
- Aseptic filling of pre-filled syringes, cartridges, and vials
- Focus on sustainability, reflected in B Corp certification and commitment to environmental stewardship
- Partnership with BD for advancing efficiency and quality in aseptic manufacturing with RFID-enabled prefillable syringes
- Collaboration with Ypsomed for the commercialization of patch injectors
- Strategic partnership with SHL Medical for integrated drug/device combination product services